This paper describes a two-year performance evaluation of four different constructed wetland (CW) treatment systems designed by IRIDRA Srl, located in central Italy. All four CW systems were established to treat wastewater effluent from different tourist activities: (1) one single-stage CW for secondary treatment of domestic wastewater (30 p.e.) at a holiday farm site; (2) a hybrid compact system consisting of two stages, a horizontal flow (HF) system followed by a vertical flow (VF) system for the secondary treatment of effluent from a 140 p.e. tourist resort; (3) a single-stage vertical flow (VF) CW for a 100 p.e. mountain shelter; and (4) a pair of single-stage, HF CWs for the secondary treatment of segregated grey and black water produced by an 80 p.e. camping site. These tourism facilities are located in remote areas and share some common characteristics concerning their water management: they have high variability of water consumption and wastewater flow, depending on the season, weather and weekly regularities; they have no connection to a public sewer and most sites are located in a sensitive environment. Total suspended solids (TSS), chemical oxygen demand (COD), biochemical oxygen demand (BOD5), ammonium (N-NH4+), nitrate (N-NOx), total nitrogen (Ntot), total phosphorus (Ptot), total coliform (TC), faecal coliform (FC), E. coli removal efficiencies for all four CW systems are presented. The results from this study demonstrate the potential of CWs as a suitable technology for treating wastewater from tourism facilities in remote areas. A very efficient COD reduction (83-95%) and pathogen elimination (3-5 logs) have been achieved. Furthermore, the CWs are easily maintained, robust (not sensitive to peak flows), constructed with local materials, and operate with relatively low cost.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2166/wst.2007.507 | DOI Listing |
Pharmazie
December 2024
Centre of Excellence for Pharmaceutical Sciences (Pharmacen™), North-West University, Potchefstroom, Republic of South Africa.
The COVID-19 pandemic caused global pandemonium, and due to an unprecedented global response, the popularity and use of (veterinary) ivermectin, amongst many other conceivable 'treatments', experienced a meteoric rise. Ivermectin is a macrocyclic lactone compound belonging to the avermectin drug class and is a registered medicine in many countries, although the most common use is as veterinary medicine. In this study, a fast HPLC method was developed and validated for the quantification of ivermectin in veterinary products that were used off-label by a substantial number of people during COVID-19.
View Article and Find Full Text PDFNeurosurg Rev
January 2025
Hengyang Key Laboratory of Hemorrhagic Cerebrovascular Disease, Department of Neurosurgery, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421000, Hunan, China.
Patients with intracranial aneurysms (IA) undergoing endovascular treatment face varying risks and benefits when tirofiban is used for thromboprophylaxis during surgery. Currently, there is a lack of high-level evidence summarizing this information. This study aims to conduct a systematic review and meta-analysis to evaluate the efficacy and safety of tirofiban during endovascular treatment of IA.
View Article and Find Full Text PDFBrain Imaging Behav
January 2025
Macquarie Medical School, Macquarie University, Sydney, NSW, Australia.
Magnetic resonance imaging (MRI) is frequently used to monitor disease progression in multiple sclerosis (MS). This study aims to systematically evaluate the correlation between MRI measures and histopathological changes, including demyelination, axonal loss, and gliosis, in the central nervous system of MS patients. We systematically reviewed post-mortem histological studies evaluating myelin density, axonal loss, and gliosis using quantitative imaging in MS.
View Article and Find Full Text PDFCardiovasc Intervent Radiol
January 2025
Department of Radiology, University Hospital of Saint Etienne, Avenue Albert Raymond, 42055, Saint-Priest-en-Jarez, Saint-Etienne Cedex 2, France.
Introduction: Aneurysmal bone cysts are locally aggressive bone lesions. The aim of this study was to evaluate safety and effectiveness of radio-opaque gelified ethanol sclerotherapy in treating primary aneurysmal bone cyst.
Materials And Methods: In this single-center, retrospective study (January 1st, 2012, to June 30th, 2024), 32 patients with primary aneurysmal bone cysts were treated with percutaneous sclerotherapy using radio-opaque gelified ethanol at various skeletal sites.
Sci Rep
January 2025
Department of Pharmacy, Nhan Dan Gia Dinh Hospital, Ho Chi Minh City, Vietnam.
Evidence of antihypertensive drug-related problems (aDRP) is limited in Asian ambulatory care. To better detect aDRP without causing alert fatigue, we investigated whether adding more antihypertensive agents was associated with increasing aDRP risk and factors associated with physician acceptance of aDRP correction. We conducted a cross-sectional study targeting ambulatory prescriptions of Vietnamese patients with hypertension who either received standard therapy (using two or fewer medications, SdT) or standard plus add-on therapy (using more than two medications, SdT + add-on).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!